These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 16641660

  • 1. The impact of physician attitudes and beliefs on treatment decisions: lipid therapy in high-risk patients.
    Foley KA, Denke MA, Kamal-Bahl S, Simpson R, Berra K, Sajjan S, Alexander CM.
    Med Care; 2006 May; 44(5):421-8. PubMed ID: 16641660
    [Abstract] [Full Text] [Related]

  • 2. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP.
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [Abstract] [Full Text] [Related]

  • 3. Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record database.
    Fox KM, Gandhi SK, Ohsfeldt RL, Blasetto JW, Davidson MH.
    Clin Ther; 2007 Nov; 29(11):2385-94. PubMed ID: 18158079
    [Abstract] [Full Text] [Related]

  • 4. Statin therapy in Canadian patients with hypercholesterolemia: the Canadian Lipid Study -- Observational (CALIPSO).
    Bourgault C, Davignon J, Fodor G, Gagné C, Gaudet D, Genest J, Lavoie MA, Leiter L, McPherson R, Sénécal M, Marentette M, Sebaldt RJ.
    Can J Cardiol; 2005 Nov; 21(13):1187-93. PubMed ID: 16308595
    [Abstract] [Full Text] [Related]

  • 5. Treatment of hypercholesterolemia in patients with diabetes at a family practice office.
    Camenga D, Gill JM.
    Del Med J; 2003 Nov; 75(11):415-20. PubMed ID: 14870630
    [Abstract] [Full Text] [Related]

  • 6. Effects of direct-to-consumer advertising of hydroxymethylglutaryl coenzyme a reductase inhibitors on attainment of LDL-C goals.
    Bradford WD, Kleit AN, Nietert PJ, Ornstein S.
    Clin Ther; 2006 Dec; 28(12):2105-18; discussion 2104. PubMed ID: 17296467
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.
    Fox KM, Gandhi SK, Ohsfeldt RL, Blasetto JW, Bays HE.
    Curr Med Res Opin; 2007 Sep; 23(9):2125-33. PubMed ID: 17655813
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Understanding practice patterns and low-density lipoprotein cholesterol goal attainment implications of switching patients from simvastatin in a health plan setting.
    Harley CR, Gandhi SK, Anoka N, Bullano MF, McKenney JM.
    Am J Manag Care; 2007 Dec; 13 Suppl 10():S276-81. PubMed ID: 18095778
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hypercholesterolemia treatment patterns and low-density lipoprotein cholesterol monitoring in patients with a diagnosis of atherosclerosis in clinical practice.
    Davidson MH, Gandhi SK, Ohsfeldt RL, Fox KM.
    Am J Med; 2009 Jan; 122(1 Suppl):S51-9. PubMed ID: 19110088
    [Abstract] [Full Text] [Related]

  • 12. Guideline-oriented ambulatory lipid-lowering therapy of patients at high risk for cardiovascular events by cardiologists in clinical practice: the 2L cardio registry.
    Gitt AK, Juenger C, Jannowitz C, Karmann B, Senges J, Bestehorn K.
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):438-44. PubMed ID: 19369876
    [Abstract] [Full Text] [Related]

  • 13. Gap between guidelines and practice: attainment of treatment targets in patients with primary hypercholesterolemia starting statin therapy. Results of the 4E-Registry (Efficacy Calculation and Measurement of Cardiovascular and Cerebrovascular Events Including Physicians' Experience and Evaluation).
    Assmann G, Benecke H, Neiss A, Cullen P, Schulte H, Bestehorn K.
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):776-83. PubMed ID: 17001218
    [Abstract] [Full Text] [Related]

  • 14. Effectiveness and cost-effectiveness of rosuvastatin, atorvastatin, and simvastatin among high-risk patients in usual clinical practice.
    Ohsfeldt RL, Gandhi SK, Fox KM, Stacy TA, McKenney JM.
    Am J Manag Care; 2006 Nov; 12(15 Suppl):S412-23. PubMed ID: 17112329
    [Abstract] [Full Text] [Related]

  • 15. The impact of reimbursement criteria on the appropriateness of 'statin' prescribing.
    Autier P, Creplet J, Vansant G, Brohet C, Paquot N, Muls E, Mullie P, Grivegnée AR.
    Eur J Cardiovasc Prev Rehabil; 2003 Dec; 10(6):456-62. PubMed ID: 14671469
    [Abstract] [Full Text] [Related]

  • 16. Results of a cross-sectional survey about lipid-management practices among cardiologists in Pakistan: assessment of adherence to published treatment guidelines.
    Gowani SA, Shoukat S, Taqui AM, Bhulani N, Khalid S, Sheikh A, Halim MS, Samreen S, Jafary FH.
    Clin Ther; 2009 Jul; 31(7):1604-14. PubMed ID: 19695410
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.
    Alsheikh-Ali AA, Lin JL, Abourjaily P, Ahearn D, Kuvin JT, Karas RH.
    Am J Cardiol; 2007 Nov 15; 100(10):1499-501. PubMed ID: 17996508
    [Abstract] [Full Text] [Related]

  • 18. Achieving target cholesterol levels in diabetic patients: potency of the statin or potency of the physician?
    Shani M, Dresner J, Vinker S.
    Isr Med Assoc J; 2008 May 15; 10(5):354-7. PubMed ID: 18605358
    [Abstract] [Full Text] [Related]

  • 19. Medicare-eligible patients diagnosed with atherosclerosis: patterns in statin therapy and lipid monitoring.
    Ohsfeldt RL, Gandhi SK, Fox KM.
    Curr Med Res Opin; 2009 Jun 15; 25(6):1403-11. PubMed ID: 19422282
    [Abstract] [Full Text] [Related]

  • 20. Cardiovascular risk assessment and treatment to target low density lipoprotein levels in hospitalized ischemic heart disease patients: results of the HOLEM study.
    Harats D, Leibovitz E, Maislos M, Wolfovitz E, Chajek-Shaul T, Leitersdorf E, Gavish D, Gerber Y, Goldbourt U, HOLEM Study Group.
    Isr Med Assoc J; 2005 Jun 15; 7(6):355-9. PubMed ID: 15984375
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.